BlueCrest Capital Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-20,164
Closed -$4.92M – 1131
2018
Q3
$4.92M Buy
+20,164
New +$4.66M 0.13% 111
2016
Q1
– Sell
-6,225
Closed -$250K – 943
2015
Q4
$250K Sell
6,225
-4,780
-43% -$202K 0.01% 781
2015
Q3
$534K Buy
+11,005
New +$523K 0.02% 578

Other funds holding INGN

BlueCrest Capital Management's INGN Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Inogen (INGN) in Q4 2018, closing a stake of 20,164 shares — an estimated $4.92M sold.

BlueCrest Capital Management first reported a position in INGN in Q3 2015 and held it in 3 quarters. The position peaked at $4.92M in Q3 2018. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 20,164 Inogen shares in Q4 2018, an estimated $4.92M.
  • BlueCrest Capital Management first reported a position in Inogen in Q3 2015 and held it in 3 quarters.
  • BlueCrest Capital Management's Inogen position peaked at $4.92M in Q3 2018.
  • 271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.